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Association between polymorphism of genes encoding for 5-HT1A and 5-HT2A 
receptors and response to selective serotonin reuptake inhibitors in Malaysian patients 
with major depressive disorder 
ABSTRACT 
Inter-racial variations in genotype frequency have been implicated as a probable cause of the 
inconsistencies in pharmacogenetic studies of major depressive disorder (MDD). The aim of 
this study was to determine whether the polymorphisms of the serotonin 1A (5HT1A) 
1019C>G and serotonin 2A (5HT2A) 1438A>G are associated with response to SSRI 
treatment among Malaysian MDD patients. These polymorphic changes are shown to 
modulate the transcription of these genes and are associated with attenuation of the density of 
the encoded receptors. Modulation of these receptors is central to the activity of 
antidepressant medication. The study involved six weeks follow up of incidence and 
prevalence (diagnosed within 2 years to recruitment) MDD patients from a case-control 
hospital based study in Malaysia. Only Malaysians aged 18–65 years and diagnosed with 
MDD (other Axis 1 psychiatric diagnosis were excluded) on treatment with SSRIs were 
recruited. One hundred and ninety two patients (females - 71.4% and males – 28.6%) were 
recruited. A total of 77.7% of the patient showed response to treatment and the rest did not. 
The response rate was also highest among the females (81%) compared to males (67%). The 
frequencies of the genotypes 5HT1A1019C>G were GC (34.2%), CC (55.2%), GG (10%) 
and those of the 5HT2A 1438A>G were GA (45.3%), AA (33%), GG (21.9%). Association 
testing for response to SSRIs with the 5HT1A 1019C>G polymorphism and not the 
5HT2A1438A>G polymorphism revealed a chi-square score of 3.911 with P≤0.05 (P=0.048) 
in a dominant model of inheritance. This study revealed that the dominant effect of the G-
allele in both the GG and GC genotypes of the 5HT1A receptor gene was associated with 
treatment response in Malaysian MDD patients. 
